MedPath

Adjunctive use of enamel matrix derivatives to porcine derived xenograft for the treatment of one-wall intrabony defects: two-year longitudinal results of a randomized controlled clinical trial

Not Applicable
Completed
Conditions
Not Applicable
Registration Number
KCT0004164
Lead Sponsor
Wonkwang University Daejeon Dental Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
50
Inclusion Criteria

(1) age = 19 years
(2) must have completed conventional periodontal treatment (scaling and root planning) at the surgical site
(3) presence of a one-wall intrabony defect (> 3 mm) in molar teeth
(4) healthy or well-controlled systemic conditions for surgical intervention (patients were American Society of Anesthesiology [ASA]-1 or ASA-2)
(5) Adequate plaque control and stable periodontal status (full mouth bleeding score on probing: < 25%, and full mouth plaque score: < 25%).

Exclusion Criteria

(1) intrabony defects extending into furcation area
(2) Open flap debridement completed within six months at the same surgical site
(3) pregnant or lactating women
(4) current smokers
(5) those who did not fully understand the purpose of the experiment and did not provide informed consent.

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.